🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading c...
Status
Recruiting
Location
City of Hope /ID# 261468
Start Date
2024-01-11
Trial ID
NCT06109272
Treatments Being Tested
This is a randomized, open-label, multi-center, international, Phase II stu...
Status
Recruiting
Location
Hospital of the University of Munich
Start Date
2023-04-06
Trial ID
NCT05844046
Treatments Being Tested
This multicenter, prospective, randomized, controlled, open-label, two-arm ...
Status
Recruiting
Location
Jinan, Shandong 0531
Start Date
2025-07-21
Trial ID
NCT06841172
This is a observational study to investigate how the microbiome correlates ...
Status
Unknown
Location
Royal United Hospitals Bath NHS Foundation Trust
Start Date
2020-07-08
Trial ID
NCT04107168
Treatments Being Tested
This phase III trial compares the effect of immunotherapy (IO) with stereot...
Status
Recruiting
Location
Alta Bates Summit Medical Center-Herrick Campus
Start Date
2026-02-26
Trial ID
NCT07166406
First-line immunotherapy-based standard of care and local ablative treatmen...
Status
Recruiting
Location
Institut de Radiothérapie du Sud de l'Oise
Start Date
2025-09-09
Trial ID
NCT06840782
Treatments Being Tested
To evaluate the efficacy and safety of HAIC combined with Durvalumab, Treme...
Status
Unknown
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2023-06-20
Trial ID
NCT05864755
Treatments Being Tested
\- Background Hepatocellular carcinoma (HCC), is the fifth most common canc...
Status
Recruiting
Location
Ospedali Riuniti Ancona, Via Conca, 71, 60126 Torrette AN
Start Date
2022-12-21
Trial ID
NCT06806579
This is a multicenter, open-label, stratified, randomized study to evaluate...
Status
Active Not Recruiting
Location
Research Site
Start Date
2015-10-19
Trial ID
NCT02519348
Treatments Being Tested
Study Objectives： Atezolizumab (anti-programmed death-ligand 1; anti-PD-L1)...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-15
Trial ID
NCT07168668
Treatments Being Tested